Adrian Caplanusi
R&D Center
Waver, VLG, Belgium
Waver, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants.
Journal: Human vaccines & immunotherapeutics
Published: August 24, 2021
Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates.
Journal: The Journal of infectious diseases
Published: March 29, 2019
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: August 23, 2018
Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.
Journal: Human vaccines & immunotherapeutics
Published: June 15, 2018
Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studies.
Journal: Human vaccines & immunotherapeutics
Published: July 16, 2015
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.
Journal: The Pediatric infectious disease journal
Published: June 13, 2015
Vaccine for prevention of mild and moderate-to-severe influenza in children.
Journal: The New England journal of medicine
Published: December 17, 2013
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.
Journal: The Lancet. Infectious diseases
Published: March 23, 2013
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.
Journal: BMC infectious diseases
Published: February 14, 2013
An assessment of prime-boost vaccination schedules with AS03A -adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults.
Journal: Influenza and other respiratory viruses
Published: March 13, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026